Pure Global AI
NCT05997329Not yet recruiting

Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home

University of OsloClinicalTrials.govother
Verified
Study focus
Disease/Condition
Head and Neck Cancer
Drug/Device/Intervention
App for diet record (MyFood)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Oslo
Location
Oslo,Oslo, Norway
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Dec 31, 2025
Enrollment
125 participants
Primary outcome

Malnutrition

Summary

Patients with cancer have increased risk of malnutrition due to the disease itself and the
 treatment regimen they undergo. This is particularly relevant for patients with head and neck
 cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers,
 including oral cavity, larynx, pharynx and salivary glands. The present project will study
 the effectiveness and implementation of remote patient monitoring of nutrition and tailored
 nutrition support throughout the treatment course in patients with head and neck cancer. The
 implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the
 project is to reduce the prevalence of malnutrition and increase the quality of life among
 patients with HNC.

ICD-10 classifications
Malignant neoplasm of other and ill-defined sites: Head, face and neckMalignant neoplasm: Skin of scalp and neckMalignant neoplasm: Connective and soft tissue of head, face and neckCarcinoma in situ: Skin of scalp and neckSecondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05997329
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05997329 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Oslo and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 125 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.